Big pharma is looking to fatten profits with buyouts of weight-loss drug companies. Here are 4 candidates.
Even if they’re not acquired, these small companies are developing promising obesity and diabetes treatments.
Peacock is raising prices again, a year after its last price hike and just in time for the Summer Olympics.
Pfizer and Genmab on Monday said they had received full approval from U.S. regulators for their treatment for certain forms...
Shares of Coursera Inc. and Chegg Inc. fell in the after-hours session Monday after both education-tech companies guided for weaker...
AT&T’s decisions in recent years look better than those made by rivals, according to Barclays.
Media and entertainment giant Paramount Global on Monday said that Chief Executive Bob Bakish was stepping down and would be...
After the skinny jean’s nearly two-decade reign, retailers and clothing makers say looser fits are getting more popular.
Average Rating